Date	Period	Revenue/Estimate	Earnings Call
Oct 31, 2024	2024/Q3	2.119B / --	--
Aug 31, 2024	2024/Q2	2.630B / --	--
Apr 30, 2024	2024/Q1	2.499B / --	--
Oct 31, 2023	2023/Q3	1.913B / --	--
Aug 31, 2023	2023/Q2	2.235B / --	--

DatePeriodRevenue/EstimateEarnings Call

Oct 31, 20242024/Q32.119B / ----

Aug 31, 20242024/Q22.630B / ----

Apr 30, 20242024/Q12.499B / ----

Oct 31, 20232023/Q31.913B / ----

Aug 31, 20232023/Q22.235B / ----

Unlock Free Earnings Estimates

Open Account

Zhejiang Huahai Pharmaceutical Earnings Reports

Huahai Pharmaceutical: Zhejiang Huahai Pharmaceutical Co., Ltd. 2024 Annual Results Advance Announcement

Jan 21 11:00 ET

Zhejiang Huahai Pharmaceutical Co., Ltd. 2024 Annual Results Advance Notice

Jan 21 11:00 ET

Huahai Pharmaceutical: Zhejiang Huahai Pharmaceutical Co., Ltd. Third Quarter Report 2024

Oct 30, 2024 12:00 ET

Zhejiang Huahai Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 30, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Shenzhen Kaifa Technology

920029

76.06 +150.36%

Shanghai Yongli Belting

300230

5.93 +20.04%

Guomai Culture & Media

301052

33.42 +20.00%

WuHan Hvsen Biotechnology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 30, 2025

Strong Buy

Strong Buy
90.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
10.00%

Price Target

No Data

Investment Theme

Monoclonal Antibody Concept